title: Measuring the effect of amantadine in chronic anoxic minimally conscious state.
authors.forename: C
authors.initials: C
authors.lastname: Schnakers
authors.forename: R
authors.initials: R
authors.lastname: Hustinx
authors.forename: G
authors.initials: G
authors.lastname: Vandewalle
authors.forename: S
authors.initials: S
authors.lastname: Majerus
authors.forename: G
authors.initials: G
authors.lastname: Moonen
authors.forename: M
authors.initials: M
authors.lastname: Boly
authors.forename: A
authors.initials: A
authors.lastname: Vanhaudenhuyse
authors.forename: S
authors.initials: S
authors.lastname: Laureys
mesh_terms: D000328:Adult; D000547:Amantadine / Q000627:therapeutic use*; D001143:Arousal / Q000187:drug effects; D001786:Blood Glucose / Q000378:metabolism; D002540:Cerebral Cortex / Q000187:drug effects; D004334:Drug Administration Schedule; D004734:Energy Metabolism / Q000187:drug effects; D019788:Fluorodeoxyglucose F18; D006801:Humans; D002534:Hypoxia, Brain / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D009483:Neuropsychological Tests; D018458:Persistent Vegetative State / Q000175:diagnosis / Q000188:drug therapy*; D049268:Positron-Emission Tomography
chemical_list: D001786:Blood Glucose; D019788:Fluorodeoxyglucose F18; D000547:Amantadine